Cite
Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years.
MLA
Klein, Reinhild, et al. “Antimitochondrial Antibody Profiles in Primary Biliary Cirrhosis Distinguish at Early Stages between a Benign and a Progressive Course: A Prospective Study on 200 Patients Followed for 10 Years.” Liver, vol. 17, no. 3, June 1997, pp. 119–28. EBSCOhost, https://doi.org/10.1111/j.1600-0676.1997.tb00793.x.
APA
Klein, R., Pointner, H., Zilly, W., Glässner-Bittner, B., Breuer, N., Garbe, W., Fintelmann, V., Kalk, J. F., Müting, D., Fischer, R., Tittor, W., Pausch, J., Maier, K. P., & Berg, P. A. (1997). Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years. Liver, 17(3), 119–128. https://doi.org/10.1111/j.1600-0676.1997.tb00793.x
Chicago
Klein, Reinhild, Herwig Pointner, Walter Zilly, Beate Glässner-Bittner, Norbert Breuer, Wolfram Garbe, Volker Fintelmann, et al. 1997. “Antimitochondrial Antibody Profiles in Primary Biliary Cirrhosis Distinguish at Early Stages between a Benign and a Progressive Course: A Prospective Study on 200 Patients Followed for 10 Years.” Liver 17 (3): 119–28. doi:10.1111/j.1600-0676.1997.tb00793.x.